Recursion
@recursionpharma.bsky.social
Decoding biology to radically improve lives. The industrial revolution of drug discovery is here. Learn more at recursion.com #techbio
At the inaugural TEDx Tribeca on Dec. 3, Recursion incoming CEO and current Chief R&D Officer and Chief Commercial Officer Najat Khan will present her personal journey merging science and technology to make new medicines and improve the lives of patients. www.ted.com/tedx/events/... #NYC #TED #TEDx
November 10, 2025 at 2:22 PM
At the inaugural TEDx Tribeca on Dec. 3, Recursion incoming CEO and current Chief R&D Officer and Chief Commercial Officer Najat Khan will present her personal journey merging science and technology to make new medicines and improve the lives of patients. www.ted.com/tedx/events/... #NYC #TED #TEDx
Recursion announced a leadership transition plan to drive the next phase of its growth. Effective Jan. 1st, Chris Gibson, Co-Founder and CEO, will transition to Chairman of the Board, Najat Khan, PhD, Chief R&D and Commercial Officer, will be named CEO and President. ir.recursion.com/news-release...
November 6, 2025 at 3:34 PM
Recursion announced a leadership transition plan to drive the next phase of its growth. Effective Jan. 1st, Chris Gibson, Co-Founder and CEO, will transition to Chairman of the Board, Najat Khan, PhD, Chief R&D and Commercial Officer, will be named CEO and President. ir.recursion.com/news-release...
In our latest Explain the Impact video, we share the inside story of the world's first Microglia Map from Recursion and Roche and Genentech to help unlock new targets in neurodegenerative diseases. #neuroscience #techbio youtube.com/shorts/xvPIQ...
The Making of the World's First Microglia Map to Explore New Targets for Neurological Diseases
YouTube video by Recursion
youtube.com
November 4, 2025 at 1:47 PM
In our latest Explain the Impact video, we share the inside story of the world's first Microglia Map from Recursion and Roche and Genentech to help unlock new targets in neurodegenerative diseases. #neuroscience #techbio youtube.com/shorts/xvPIQ...
💥 Recursion has achieved a $30 million milestone payment from its partners, Roche and Genentech, following the acceptance of the Microglia Map – a first-of-its-kind whole genome map of the brain’s immune cells.
👉Learn more: www.recursion.com/news/how-a-f... #neuroscience #TechBio
👉Learn more: www.recursion.com/news/how-a-f... #neuroscience #TechBio
How a First-of-its-Kind “Microglia Map” from Recursion and Roche and Genentech Could Unlock New Treatments for Neurodegenerative Diseases
A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide range of neurological dise...
www.recursion.com
October 31, 2025 at 2:46 PM
💥 Recursion has achieved a $30 million milestone payment from its partners, Roche and Genentech, following the acceptance of the Microglia Map – a first-of-its-kind whole genome map of the brain’s immune cells.
👉Learn more: www.recursion.com/news/how-a-f... #neuroscience #TechBio
👉Learn more: www.recursion.com/news/how-a-f... #neuroscience #TechBio
The 3rd episode of TechBio Talks is now live, featuring leading AI investor Nathan Benaich of Air Street Capital with host Chris Gibson discussing the evolving landscape of AI in drug discovery, the biggest trends in Nathan’s new State of AI Report, and more! www.youtube.com/watch?v=MUjT...
TechBio Talks Episode 3: Air Street Capital's Nathan Benaich with Host Chris Gibson
YouTube video by Recursion
www.youtube.com
October 28, 2025 at 4:45 PM
The 3rd episode of TechBio Talks is now live, featuring leading AI investor Nathan Benaich of Air Street Capital with host Chris Gibson discussing the evolving landscape of AI in drug discovery, the biggest trends in Nathan’s new State of AI Report, and more! www.youtube.com/watch?v=MUjT...
What gets you excited?
In this video, Communications and Culture Fellow Katherine Matsumoto asks Recursionauts to share the “one thing” that most excites them about their work. #OneThing #culture
www.youtube.com/shorts/zQDQq...
In this video, Communications and Culture Fellow Katherine Matsumoto asks Recursionauts to share the “one thing” that most excites them about their work. #OneThing #culture
www.youtube.com/shorts/zQDQq...
One Thing That Makes Me Excited to Come to Work at Recursion
YouTube video by Recursion
www.youtube.com
October 16, 2025 at 1:42 PM
What gets you excited?
In this video, Communications and Culture Fellow Katherine Matsumoto asks Recursionauts to share the “one thing” that most excites them about their work. #OneThing #culture
www.youtube.com/shorts/zQDQq...
In this video, Communications and Culture Fellow Katherine Matsumoto asks Recursionauts to share the “one thing” that most excites them about their work. #OneThing #culture
www.youtube.com/shorts/zQDQq...
Today, cofounder & CEO Chris Gibson spoke on the Main Stage at #GITEX to discuss how the convergence of AI, data, & DNA is fundamentally changing the way we discover medicines. As he wrote: “This is more than just a shift in technology — it’s a re-architecting of the scientific process itself."
October 15, 2025 at 2:23 PM
Today, cofounder & CEO Chris Gibson spoke on the Main Stage at #GITEX to discuss how the convergence of AI, data, & DNA is fundamentally changing the way we discover medicines. As he wrote: “This is more than just a shift in technology — it’s a re-architecting of the scientific process itself."
🎫 Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan, PhD will join leading experts from healthcare, technology, and public policy for Google Cloud’s Cancer AI Symposium on Oct. 30 at Google NYC, exploring how #AI is currently transforming #cancer care – and what’s to come. 🧪
October 13, 2025 at 3:24 PM
Inside the AI transformation of drug discovery.
On Oct. 15 on the Main Stage of GITEX Global at the Dubai World Trade Center, Recursion cofounder & CEO Chris Gibson will give a keynote on "AI, Data & DNA: TechBio’s Disruption of Drug Discovery." 👉 visit.gitex.com
#GITEXGlobal #GITEX2025 #TechBio
On Oct. 15 on the Main Stage of GITEX Global at the Dubai World Trade Center, Recursion cofounder & CEO Chris Gibson will give a keynote on "AI, Data & DNA: TechBio’s Disruption of Drug Discovery." 👉 visit.gitex.com
#GITEXGlobal #GITEX2025 #TechBio
October 6, 2025 at 1:49 PM
Inside the AI transformation of drug discovery.
On Oct. 15 on the Main Stage of GITEX Global at the Dubai World Trade Center, Recursion cofounder & CEO Chris Gibson will give a keynote on "AI, Data & DNA: TechBio’s Disruption of Drug Discovery." 👉 visit.gitex.com
#GITEXGlobal #GITEX2025 #TechBio
On Oct. 15 on the Main Stage of GITEX Global at the Dubai World Trade Center, Recursion cofounder & CEO Chris Gibson will give a keynote on "AI, Data & DNA: TechBio’s Disruption of Drug Discovery." 👉 visit.gitex.com
#GITEXGlobal #GITEX2025 #TechBio
Announcing TechBio Talks Episode 2: A deep dive into phenomics, open science and virtual cells.
Host Chris Gibson talks to the Broad Institute's Anne Carpenter, a pioneer in image-based profiling, who played a key role in Recursion’s origin story. 🧵
Host Chris Gibson talks to the Broad Institute's Anne Carpenter, a pioneer in image-based profiling, who played a key role in Recursion’s origin story. 🧵
October 2, 2025 at 1:34 PM
Announcing TechBio Talks Episode 2: A deep dive into phenomics, open science and virtual cells.
Host Chris Gibson talks to the Broad Institute's Anne Carpenter, a pioneer in image-based profiling, who played a key role in Recursion’s origin story. 🧵
Host Chris Gibson talks to the Broad Institute's Anne Carpenter, a pioneer in image-based profiling, who played a key role in Recursion’s origin story. 🧵
In a clip from our podcast TechBio Talks, MIT's Regina Barzilay tells host Najat Khan how we can leverage machine learning to better predict how a patient will respond to treatments, to improve his or her condition for the “longest time with minimal side effects.” www.youtube.com/shorts/uSEM1... 🧵
Using Machine Learning to Predict Patient Response to Treatment
YouTube video by Recursion
www.youtube.com
September 23, 2025 at 1:53 PM
In a clip from our podcast TechBio Talks, MIT's Regina Barzilay tells host Najat Khan how we can leverage machine learning to better predict how a patient will respond to treatments, to improve his or her condition for the “longest time with minimal side effects.” www.youtube.com/shorts/uSEM1... 🧵
We♥️our innovators.
Recursion was recognized as one of the “Best Workplaces for Innovators” by @fastcompany.com.
At Recursion, we're building a new kind of drug discovery & development platform from the ground up – relentlessly working toward a better way to bring new medicines to patients. 🧵
Recursion was recognized as one of the “Best Workplaces for Innovators” by @fastcompany.com.
At Recursion, we're building a new kind of drug discovery & development platform from the ground up – relentlessly working toward a better way to bring new medicines to patients. 🧵
September 22, 2025 at 1:48 PM
We♥️our innovators.
Recursion was recognized as one of the “Best Workplaces for Innovators” by @fastcompany.com.
At Recursion, we're building a new kind of drug discovery & development platform from the ground up – relentlessly working toward a better way to bring new medicines to patients. 🧵
Recursion was recognized as one of the “Best Workplaces for Innovators” by @fastcompany.com.
At Recursion, we're building a new kind of drug discovery & development platform from the ground up – relentlessly working toward a better way to bring new medicines to patients. 🧵
A recent story in @reuters.com looks at momentum happening in #AI drug discovery, noting that AI adoption across the #pharma industry will lead to “faster and cheaper results” including through reduction in animal testing, a recent push from the #FDA. More: www.reuters.com/business/hea...
September 18, 2025 at 1:29 PM
A recent story in @reuters.com looks at momentum happening in #AI drug discovery, noting that AI adoption across the #pharma industry will lead to “faster and cheaper results” including through reduction in animal testing, a recent push from the #FDA. More: www.reuters.com/business/hea...
“We’re focused on going places that we don’t think other people can.” On 9/8, Chris Gibson & Najat Khan presented at the Morgan Stanley Global Healthcare Conference, addressing macro concerns, platform evolution & what we anticipate from partnership milestones
👉 event.webcasts.com/viewer/event...
👉 event.webcasts.com/viewer/event...
September 16, 2025 at 2:15 PM
“We’re focused on going places that we don’t think other people can.” On 9/8, Chris Gibson & Najat Khan presented at the Morgan Stanley Global Healthcare Conference, addressing macro concerns, platform evolution & what we anticipate from partnership milestones
👉 event.webcasts.com/viewer/event...
👉 event.webcasts.com/viewer/event...
A new feature in @financialtimes.com looks at what’s needed for #AI drug discovery to begin delivering on its promises and how the latest #ML breakthroughs paired with over a decade of fit-for-purpose data generation has positioned us for that moment.
👉 www.ft.com/content/9a8a...
👉 www.ft.com/content/9a8a...
September 15, 2025 at 2:41 PM
A new feature in @financialtimes.com looks at what’s needed for #AI drug discovery to begin delivering on its promises and how the latest #ML breakthroughs paired with over a decade of fit-for-purpose data generation has positioned us for that moment.
👉 www.ft.com/content/9a8a...
👉 www.ft.com/content/9a8a...
🌄 The peak is now the basecamp.
A new feature in @pharmaphorum.bsky.social looks at how Recursion has built the necessary foundation & is now accelerating into a new era of AI-led drug discovery, focused on delivering transformative, first-in-class medicines. pharmaphorum.com/deep-dive/ai...
A new feature in @pharmaphorum.bsky.social looks at how Recursion has built the necessary foundation & is now accelerating into a new era of AI-led drug discovery, focused on delivering transformative, first-in-class medicines. pharmaphorum.com/deep-dive/ai...
September 11, 2025 at 3:07 PM
🌄 The peak is now the basecamp.
A new feature in @pharmaphorum.bsky.social looks at how Recursion has built the necessary foundation & is now accelerating into a new era of AI-led drug discovery, focused on delivering transformative, first-in-class medicines. pharmaphorum.com/deep-dive/ai...
A new feature in @pharmaphorum.bsky.social looks at how Recursion has built the necessary foundation & is now accelerating into a new era of AI-led drug discovery, focused on delivering transformative, first-in-class medicines. pharmaphorum.com/deep-dive/ai...
In an interview with Occam, Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan outlines the strategy for building a #TechBio company that’s positioned to win.
👉 Read more: www.occam-global.com/blogs/an-int...
👉 Read more: www.occam-global.com/blogs/an-int...
Read Occam's interview with AIDD leader Najat Khan, PhD. | Occam Global
Read Occam's interview with AIDD leader Najat Khan, PhD.
www.occam-global.com
September 10, 2025 at 1:18 PM
In an interview with Occam, Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan outlines the strategy for building a #TechBio company that’s positioned to win.
👉 Read more: www.occam-global.com/blogs/an-int...
👉 Read more: www.occam-global.com/blogs/an-int...
🎉 Daniel Cohen, President of Valence Labs (@valenceai.bsky.social),
Recursion’s AI research engine, has been named a “Rising Leader” by Citeline. #TechBio #AI #ML #research #virtualcell
👉Read more: insights.citeline.com/in-vivo/lead...
Recursion’s AI research engine, has been named a “Rising Leader” by Citeline. #TechBio #AI #ML #research #virtualcell
👉Read more: insights.citeline.com/in-vivo/lead...
September 5, 2025 at 1:45 PM
🎉 Daniel Cohen, President of Valence Labs (@valenceai.bsky.social),
Recursion’s AI research engine, has been named a “Rising Leader” by Citeline. #TechBio #AI #ML #research #virtualcell
👉Read more: insights.citeline.com/in-vivo/lead...
Recursion’s AI research engine, has been named a “Rising Leader” by Citeline. #TechBio #AI #ML #research #virtualcell
👉Read more: insights.citeline.com/in-vivo/lead...
📣 The inaugural episode of TechBio Talks is now live!
Host Najat Khan sits down w/ MIT Distinguished Professor Regina Barzilay for a fascinating conversation about the new AI technologies transforming healthcare.
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: youtube.com/playlist?lis...
Host Najat Khan sits down w/ MIT Distinguished Professor Regina Barzilay for a fascinating conversation about the new AI technologies transforming healthcare.
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: youtube.com/playlist?lis...
September 4, 2025 at 1:20 PM
📣 The inaugural episode of TechBio Talks is now live!
Host Najat Khan sits down w/ MIT Distinguished Professor Regina Barzilay for a fascinating conversation about the new AI technologies transforming healthcare.
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: youtube.com/playlist?lis...
Host Najat Khan sits down w/ MIT Distinguished Professor Regina Barzilay for a fascinating conversation about the new AI technologies transforming healthcare.
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: youtube.com/playlist?lis...
🔹 Join us in September as Recursion executives present at two upcoming investor conferences:
▪️ Sept. 3: Citi 2025 BioPharma Back to School Conference
▪️ Sept. 8: Morgan Stanley 23rd Annual Global Healthcare Conference
👉 Learn more and tune in here: ir.recursion.com.
#investor #IR #IRconference
▪️ Sept. 3: Citi 2025 BioPharma Back to School Conference
▪️ Sept. 8: Morgan Stanley 23rd Annual Global Healthcare Conference
👉 Learn more and tune in here: ir.recursion.com.
#investor #IR #IRconference
August 27, 2025 at 1:10 PM
🔹 Join us in September as Recursion executives present at two upcoming investor conferences:
▪️ Sept. 3: Citi 2025 BioPharma Back to School Conference
▪️ Sept. 8: Morgan Stanley 23rd Annual Global Healthcare Conference
👉 Learn more and tune in here: ir.recursion.com.
#investor #IR #IRconference
▪️ Sept. 3: Citi 2025 BioPharma Back to School Conference
▪️ Sept. 8: Morgan Stanley 23rd Annual Global Healthcare Conference
👉 Learn more and tune in here: ir.recursion.com.
#investor #IR #IRconference
🎙️ Introducing #TechBio Talks – a new podcast hosted by Chris Gibson & Najat Khan offering candid conversations with the scientists, founders, & investors on the frontlines of #AI drug discovery. Subscribe now:
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: www.youtube.com/playlist?lis...
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: www.youtube.com/playlist?lis...
August 26, 2025 at 1:13 PM
🎙️ Introducing #TechBio Talks – a new podcast hosted by Chris Gibson & Najat Khan offering candid conversations with the scientists, founders, & investors on the frontlines of #AI drug discovery. Subscribe now:
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: www.youtube.com/playlist?lis...
▪️ Spotify: open.spotify.com/show/2bjoBPs...
▪️ YouTube: www.youtube.com/playlist?lis...
🔹 Delivering breakthroughs, at scale. Last week, Erik Douglas, VP of Product, joined some of the biggest names in tech – including Fei-Fei Li and Geoffrey Hinton – at the #Ai4 conference in Vegas where he provided insights into our AI-driven industrialization of drug discovery and development.
August 22, 2025 at 1:17 PM
🔹 Delivering breakthroughs, at scale. Last week, Erik Douglas, VP of Product, joined some of the biggest names in tech – including Fei-Fei Li and Geoffrey Hinton – at the #Ai4 conference in Vegas where he provided insights into our AI-driven industrialization of drug discovery and development.
🚀 Expanding access to data to accelerate #AI drug discovery.
A new article from @britabelli.bsky.social in Future Medicine AI looks at the critical role open datasets play in driving discoveries & initiatives underway to enable more access. www.fmai-hub.com/how-open-dat... #TechBio #drugdiscovery
A new article from @britabelli.bsky.social in Future Medicine AI looks at the critical role open datasets play in driving discoveries & initiatives underway to enable more access. www.fmai-hub.com/how-open-dat... #TechBio #drugdiscovery
How Open Data Is Fueling the AI Drug Discovery Era - Future Medicine AI
Big pharma is unlocking decades of secret data vaults for the first time, fueling an AI revolution that's compressing 50 years of drug discovery into mere months - and the cure for tomorrow's diseases...
www.fmai-hub.com
August 20, 2025 at 3:26 PM
🚀 Expanding access to data to accelerate #AI drug discovery.
A new article from @britabelli.bsky.social in Future Medicine AI looks at the critical role open datasets play in driving discoveries & initiatives underway to enable more access. www.fmai-hub.com/how-open-dat... #TechBio #drugdiscovery
A new article from @britabelli.bsky.social in Future Medicine AI looks at the critical role open datasets play in driving discoveries & initiatives underway to enable more access. www.fmai-hub.com/how-open-dat... #TechBio #drugdiscovery
An article in BioPharmaTrend highlighted our recent earnings report, including “progress on internal assets REC-1245 (RBM39 degrader) and REC-617 (CDK7 inhibitor), alongside a $7 million milestone payment from Sanofi for a partnered immunology program.” www.biopharmatrend.com/news/recursi...
August 19, 2025 at 2:31 PM
An article in BioPharmaTrend highlighted our recent earnings report, including “progress on internal assets REC-1245 (RBM39 degrader) and REC-617 (CDK7 inhibitor), alongside a $7 million milestone payment from Sanofi for a partnered immunology program.” www.biopharmatrend.com/news/recursi...